ENGRAILED 2 (EN2) Genetic and Functional Analysis by Choi, Jiyeon et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1 
ENGRAILED 2 (EN2) Genetic 
and Functional Analysis 
Jiyeon Choi1, Silky Kamdar1, Taslima Rahman1, 
Paul G Matteson1 and James H Millonig1,2,3 
1Center for Advanced Biotechnology and Medicine, 
2Department of Neuroscience and Cell Biology, 
UMDNJ-Robert Wood Johnson Medical School, 
3Department of Genetics, Rutgers University, Piscataway NJ, 
USA 
1. Introduction 
Our autism research has focused on the homeobox transcription factor, ENGRAILED 2 
(EN2). Prior to the advent of genome wide association and re-sequencing analysis, we 
selected EN2 as a candidate gene due to neuroanatomical similarities observed between 
individuals with autism and mouse En2 mutants.  
Animal studies have demonstrated that En2 is expressed throughout CNS development and 
regulates numerous cell biological processes implicated in ASD including connectivity, 
excitatory/inhibitory (E/I) circuit balance, and neurotransmitter development. The 
relevance of these functions to ASD etiology is discussed. 
Human genetic analysis by us determined that two intronic SNPs, rs1861972 and rs1861973, 
are significantly associated with Autism Spectrum Disorder (ASD). We observed the 
common haplotype (rs1861972-rs1861973 A-C) is over-transmitted to affected individuals 
while the rs1816972-rs1861973 G-T haplotype is over-represented in unaffected siblings. 
Significant results were observed in 3 datasets (518 families, 2336 individuals, P=.00000035). 
6 other groups have also reported association of EN2 with ASD, suggesting that EN2 is an 
ASD susceptibility gene. These results are discussed. 
However if EN2 contributes to ASD risk, we would expect the ASD-associated A-C haplotype 
to segregate with a polymorphism that is functional and affects either the regulation or activity 
of EN2. Linkage disequilibrium mapping, re-sequencing and additional association analysis 
was performed, and identified the A-C haplotype as the best candidate for functional analysis. 
Luciferase assays conducted in primary mouse neuronal cultures demonstrated that the A-C 
haplotype functions as a transcriptional activator and specifically binds a protein complex. 
Transgenic mouse studies have demonstrated that the A-C haplotype is also functional, 
increasing gene expression in vivo. Finally, human post-mortem studies indicate EN2 levels are 
also increased in individuals with autism. Thus, the ASD-associated A-C haplotype is 
functional and increased EN2 levels are consistently correlated with ASD.  
Six significant CpG islands also flank human EN2. Preliminary studies indicate 
hypomethylation of these CpGs can also result in increased EN2 levels, suggesting 
www.intechopen.com
 
Autism Spectrum Disorders – From Genes to Environment 
 
4 
epigenetic alterations influenced by non-genetic environmental factors can affect EN2 levels. 
To study how genetic and epigenetic changes may function together to influence EN2 
regulation and CNS development, we are creating a chromosomal engineered knock-in that 
will replace ~75kb of mouse En2 with the human gene.  
In summary EN2 is consistently associated with ASD and functions in developmental 
pathways implicated in ASD. In addition, we have shown that the ASD-associated 
haplotype is functional, resulting in increased expression both in neuronal cultures in vitro 
and in transgenic mice in vivo. Increased levels are also observed in human post-mortem 
samples. Together these human genetic data along with our molecular, mouse and post-
mortem studies indicate that EN2 is an ASD susceptibility gene  
2. Selection of ENGRAILED 2 as a candidate gene 
Before genome-wide strategies were available for identifying common and rare variants for 
ASD, my laboratory decided to test candidate genes based upon neuroanatomical 
phenotypes. When we started this work in 2003, two cerebellar neuroanatomical phenotypes 
were consistently observed in individuals with ASD: a decrease in cerebellar volume 
(hypoplasia) and fewer Purkinje neurons (Bauman and Kemper 1985; Bauman 1986; 
Courchesne, Yeung-Courchesne et al. 1988; Courchesne 1997; Amaral, Schumann et al. 
2008). We knew of numerous mouse mutants that displayed similar morphological 
phenotypes so we decided to test these genes for association in the available Autism Genetic 
Resource Exchange (AGRE) dataset. A list of nearly 100 genes were compiled that displayed 
similar cerebellar phenotypes in the mouse and individuals with ASD. The list also included 
genes that at the time were expressed in the cerebellum in specific spatial-temporal patterns 
suggesting they were likely to contribute to development. These genes were then placed on 
the human genome to determine which ones mapped near polymorphic markers that 
displayed linkage to ASD.  
Many of the genes mapped to possibly interesting locations so we prioritized our 
association analysis by the following criteria: i) distance to SSLP marker, ii) LOD score or 
statistical significance of marker, iii) whether segregation or linkage to the chromosomal 
region had been replicated in multiple studies, iv) whether the genomic region displayed 
linkage in the AGRE dataset which would be used for our association analysis, v) whether 
mouse mutants existed for the gene, vi) and the similarity between reported mouse and 
ASD cerebellar phenotypes 
Based on these criteria we selected the homeobox transcription factor ENGRAILED 2 (EN2) 
as a candidate gene. EN2 belongs to a class of transcription factors that are homologous in 
their DNA binding domain called the homeobox. Homeobox transcription factors regulate 
gene expression by binding to AT-rich DNA elements, and play central roles in coordinating 
development. Many homeobox genes are evolutionarily conserved from Drosophila to 
humans. The engrailed gene was first identified in classical genetic screens for developmental 
regulators in Drosophila. Humans and mice have two Engrailed genes, Engrailed 1 (En1) and 
Engrailed 2 (En2). Both En1 and En2 regulate important aspects of CNS development (see 
Section 4 – ENGRAILED 2 function) 
Human EN2 maps to distal chromosome 7 (7q36.3), near markers that display linkage to 
ASD in several datasets (Liu, Nyholt et al. 2001; Alarcon, Cantor et al. 2002; Auranen, 
Vanhala et al. 2002). Two of these studies had been performed using AGRE families. In 
addition two different En2 mouse mutations existed – a traditional knock-out or deletion of 
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En2, and a transgenic misexpression mutant. In the knockout the cerebellum is reduced in 
size and cell counts have determined an ~30-40% reduction in all the major cerebellar cell 
types including Purkinje cells (Millen, Wurst et al. 1994; Kuemerle, Zanjani et al. 1997). In 
the trangenic En2 is misexpressed in a subset of Purkinje cells and similar phenotypes were 
observed (40-50% reduction in cerebellar area; ~40% decrease in the number of adult 
Purkinje cells)(Baader, Sanlioglu et al. 1998).  
Significant association of EN2 with ASD was initially demonstrated by us and has now been 
reported by 5 additional groups (Brune, Korvatska et al. 2007; Wang, Jia et al. 2008; Yang, 
Lung et al. 2008; Sen, Singh et al. 2010; Yang, Shu et al. 2010). Prior to summarizing these 
data, we will first describe the known expression of mouse and human EN2 as well as the 
cell biological processes regulated by En2 in the developing and adult brain. 
3. Engrailed 2 expression during development 
Mouse En2 expression has been evaluated primarily by in situ hybridization and lacZ knock-
in mice (see Table 1 for summary). In these studies En2 expression is initiated at E8.0 at the 
junction between the midbrain and hindbrain. En2 continues to be expressed in a majority of 
mid-hindbrain cells from E8.5 to E12.5. These En2 expressing cells will generate the 
cerebellum and midbrain colliculi dorsally, as well as parts of the serotonin (raphe nucleus) 
and norepinephrine (locus coeruleus) neurotransmitter systems ventrally. By E17.5 En2 
expression becomes more spatially restricted. In the chick tectum En2 is expressed in a 
rostral to caudal gradient, while in the cerebellum it is stripe-like. By post-natal day 6 En2 
transcripts are restricted to the differentiating cells in the external germinal layer and 
developing inner granule cell layer of the cerebellum. In the adult En2 continues to be 
expressed in mature cerebellar granule cells. Finally, QRTPCR studies indicate En2 is also 
expressed at low levels in adult hippocampus. 
 
Developmental Stage Expression Function 
E8.0-E12.5 Mid-hindbrain junction A-P patterning, 
Neurotransmitter development 
E12.5-E15.5 Developing cerebellum, 
colliculi, ventral mid- 
hindbrain nuclei including 
LC and RN, periaqueductal 
gray 
Retinal-tectal mapping, 
Neurotransmitter development 
E15.5-P0 Developing cerebellum, 
colliculi, 
Retinal-tectal mapping, 
cerebellar connectivity 
P0-P12 Cerebellum (differentiating 
Granule cells) 
Cell cycle and differentiation 
Adult Mature granule cells Unknown 
Table 1. Summary of En2 expression and function from animal studies 
A limited number of human ENGRAILED 2 expression studies have been performed. One 
analysis conducted on 18-21 weeks post-conception fetuses demonstrated widespread 
expression for both ENGRAILED 1 and 2 genes throughout the mid-hindbrain region 
including the cerebellar cortex and deep nuclei. Expression was also observed in several 
ventral hindbrain nuclei (inferior olive, arcuate nucleus, caudal raphe nucleus)(Zec, Rowitch 
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et al. 1997). Western blot analysis conducted on cerebellar samples at later gestational ages 
(40 weeks) indicated abundant expression for both EN proteins (Logan, Hanks et al. 1992). 
Interestingly, recent microarray analysis performed by The Allen Institute for Brain Science 
demonstrates abundant expression throughout the cerebellum (cortex and deep nuclei) but 
also in numerous forebrain and midbrain structures (basal ganglia, amygdala, 
thalamus)(Figure 1). A complete developmental analysis of human EN2 expression has not 
been reported. These data suggest human adult brain EN2 expression is more widespread 
than mouse En2, and in fore- and mid-brain structures relevant to ASD phenotypes.  
 
 
Fig. 1. Human EN2 expression. Microarray data of microdissected brain regions performed 
by The Allen Institute for Brain Science indicate that EN2 is expressed in the basal ganglia 
(purple), amygdala (pink), thalamus (green) as well as cerebellum and brainstem (blue). A) 
sagittal, B) horizontal, and C) caudal views 
4. ENGRAILED 2 function 
Molecular studies have determined that En2 functions as a transcriptional repressor. The 
protein regulates numerous cell biological pathways during CNS development but has a 
well-characterized function in establishing connectivity maps. Emerging data also supports 
En2 function in E/I circuit balance as well as serotonin and norepinephrine 
neurotransmitter development. All of these cellular processes have been implicated in ASD 
etiology. 
4.1 Transcriptional repressor function of En2 
Molecular studies indicate the Engrailed 2 protein primarily functions as a transcriptional 
repressor, which is mediated by several different protein domains (Figure 2). DNA binding 
occurs through the homeodomain to a generic AT rich cis-sequence recognized by 
homeobox transcription factors. Two domains (engrailed homology region 1 (EH1) and 
EH5) contribute to Engrailed repressor activity. EH1 is located in the N-terminal portion of 
the protein while the EH5 domain is immediately 3’ of the homeodomain in the C terminal 
portion of the protein. Both domains bind the co-repressor Groucho, while EH1 is sufficient 
to confer repression activity when transferred to a transcriptional activator. Engrailed 
repressor function is mediated by two different mechanisms. The protein can actively block 
the trans-activation of activators by binding to nearby cis-sequences. Alternatively, the 
engrailed proteins compete for the binding of the basal transcriptional machinery to TATA 
box sequences (Ohkuma, Horikoshi et al. 1990; Jaynes and O'Farrell 1991; Tolkunova, 
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Fujioka et al. 1998). Finally, two other domains (EH2 and EH3) bind the Pbx family of 
homeodomain transcription factors, which affect DNA biding specificity (van Dijk and 
Murre 1994; Peltenburg and Murre 1997).  
 
N C
EH1 EH2 EH3 EH4 EH5
 
Fig. 2. En protein domains. The En protein structure is illustrated and the different En 
interaction domains are demarcated in following colors: translation initiation factor eIF4E 
binding site, transcriptional repressor domains, PBX interactions domains, homeodomain, 
and penetratin domain. EH1-5 indicate engrailed homology domains 1 through 5. 
4.2 En2 regulates mid-hindbrain patterning 
Mouse and chick studies have determined that En2 coordinates multiple cell biological 
process throughout development. From E8.0-E12.5, En2 and En1 are spatially overlapping at 
the mid-hindbrain junction and both genes function to restrict progenitors to a midbrain and 
hindbrain lineage (Joyner 1996). En2 temporal expression commences a few hours after En1 
transcripts are first detected and because of this difference, the En1 knock-out mouse 
displays a more severe phenotype with a deletion of mid-hindbrain structures (Wurst, 
Auerbach et al. 1994). Knock-in experiments where En2 is targeted to the En1 locus are 
sufficient to rescue this phenotype, demonstrating that En2 is functionally redundant to En1 
at this early stage of development (Hanks, Wurst et al. 1995).  
4.3 Engrailed genes and 5HT and NE neurotransmitter system development 
Previous studies have demonstrated that the Engrailed genes are important in the 
development and maintenance of substantia nigra neurons in the dopamine 
neurotransmitter system. These data are reviewed elsewhere (Simon, Saueressig et al. 2001; 
Alberi, Sgado et al. 2004; Simon, Thuret et al. 2004; Gherbassi and Simon 2006; Sgado, Alberi 
et al. 2006). Instead we focus on the role of the En genes on serotonin (5HT) and 
norepinephrine (NE) development, since abnormalities in these neurotransmitter systems 
have been more consistently implicated in ASD. 
Mutations in the Engrailed genes affect the development of ventral mid-hindbrain nuclei 
that synthesize NE and 5HT: the locus coeruleus (LC) and raphe nuclei (RN) respectively. 
The LC is generated early in development (E9-E10 in the mouse) from the dorsal mid-
hindbrain junction. The LC is deleted in the double En1-/- En2-/- knockout mice but appears 
relatively normal in the single knockouts suggesting the genes compensate for each other 
during development. The RN is generated in the ventral mid-hindbrain and express 5HT by 
E11.5. Several transcription factors including Pet1, Lmx1b and Gata3 are important in the 
generation of RN. Recent analysis indicates that both En genes are expressed in the 
progenitors of RN at E11.5 and to continue to be expressed in post-mitotic rostral 5HT 
neurons. In addition an ~50% loss of neurons is observed in the dorsal RN by E16.5 in the 
double En knockouts. Like the LC phenotype the RN is relatively normal in the single 
knockouts suggesting the genes compensate for each other during development (Simon, 
Saueressig et al. 2001; Simon, Scholz et al. 2005; Sgado, Alberi et al. 2006; Fox 2010). 
Neurochemical data from our collaborator, Emanuel DiCicco-Bloom MD, have 
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demonstrated abnormal levels of NE and 5HT in both the fore- and hindbrain structures of 
the En2 knockout (Lin 2010). These data indicate that the development of the 5HT and NE 
neurotransmitter systems are regulated by the Engrailed proteins.  
Numerous studies have implicated the 5HT and NE pathways in ASD. The 5HT pathway 
regulates mood, eating, body temperature and arousal, some of which are often perturbed 
in individuals with ASD. Abnormalities in the 5HT pathway have been consistently 
observed in individuals with ASD. Blood platelet hyperserotonemia has been reported since 
the 1960s in ~30% of affected individuals (Ritvo, Yuwiler et al. 1970; Campbell, Friedman et 
al. 1975; Takahashi, Kanai et al. 1976; Anderson 1987; Anderson, Freedman et al. 1987; 
McBride, Anderson et al. 1989; Cook, Rowlett et al. 1992; Lam, Aman et al. 2006). However, 
several studies suggest 5HT functioning is depressed in the CNS of individuals with autism. 
For example, serotonin reuptake inhibitors (SSRIs) can improve some of the symptoms of 
ASD (Cook, Rowlett et al. 1992; Gordon, State et al. 1993). In addition, the rate-limiting step 
of 5HT synthesis is the hydroxylation of tryptophan and acute depletion of tryptophan 
worsens ASD symptoms (McDougle, Naylor et al. 1996; McDougle, Naylor et al. 1996). The 
NE neurotransmitter system regulates attention, stress, anxiety, and memory, some of which 
are also affected in individuals with ASD. Unlike the 5HT system, the peripheral and central 
NE systems are tightly coordinated. Five studies have revealed increases in NE in the blood 
(Lake, Ziegler et al. 1977; Launay, Bursztejn et al. 1987; Leventhal, Cook et al. 1990; Leboyer, 
Bouvard et al. 1992; Minderaa, Anderson et al. 1994). However since plasma NE has a very 
short half-life, it remains possible that this increase is due to arousal at the time of blood 
drawing.  
4.4 En2 regulates connectivity 
From E15.5-P0, En2 is expressed in a stripe-like pattern in the cerebellum. En2 is one of 
many patterning genes that are expressed in this stripe-like pattern at this age (En1, Shh, 
Pax2 and Wnt7b)(Millen, Hui et al. 1995). Interestingly, these stripe-like expression domains 
are coincident with the innervation of cerebellar afferents (mossy and climbing fibers), 
suggesting that these patterning genes regulate the topographic mapping of axons. 
Consistent with this possibility, En2 mouse mutants display connectivity phenotypes 
disrupting the innervation of mossy fibers (Herrup and Kuemerle 1997; Baader, Sanlioglu et 
al. 1998; Baader, Vogel et al. 1999; Sillitoe, Stephen et al. 2008; Sillitoe, Gopal et al. 2009; 
Sillitoe, Vogel et al. 2010). Thus En2 is important in establishing the cerebellar connectivity 
map during development. 
Several studies indicate the Engrailed proteins are secreted and function as axon guidance 
proteins for retinal-tectal mapping. Initial EM and protein studies from the Prochiantz 
group indicated that a subset of the Engrailed proteins are associated with caveolae-like 
vesicles (Joliot, Trembleau et al. 1997). Subsequent work demonstrated that ~5% of the 
Engrailed protein are secreted and they are internalized by neighboring cells. A protein 
sequence embedded in the homeodomain called the penetratin domain is responsible for 
this activity (Joliot, Maizel et al. 1998). In addition, in vitro cultures demonstrated that 
exogenous En2 acts as a guidance cue for isolated retinal axons transected from the nucleus. 
Imaging studies indicate En2 is endocytosed by these growth cones. The protein then 
interacts with the eukaryotic initiation factor 4E (eIF4E), and En2 mutations that prevent 
eIF4E interaction fail to cause axon turning. En2 also results in the phosphorylation of eIF4E 
and its binding protein, 4E-BP1, in axons, which is typically associated with translation 
initiation (Brunet, Weinl et al. 2005). Recent antibody experiments that block exogenous 
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activity cause significant connectivity defects in the tectum (Wizenmann, Brunet et al. 2009). 
Interestingly, several other developmentally important transcription factors (Pax6, Otx2) 
also display non-cell autonomous phenotypes (Lesaffre, Joliot et al. 2007; Sugiyama, Di 
Nardo et al. 2008), suggesting this phenomenon is not specific to the Engrailed genes. 
Thus, a small proportion of the Engrailed 2 protein is secreted and is important in regulating 
connectivity through local translation. The FMR protein, which is mutated in Fragile X 
Syndrome (FXS), also regulates local synaptic translation. Approximately one-third of 
individuals with FXS are diagnosed with ASD, suggesting synaptic translation defects could 
contribute to ASD etiology. 
En2 transcripts are also observed at low levels in the adult hippocampus. En2 knock-out 
studies revealed a decrease in the number of inhibitory GABA interneurons in the CA3 
pyramidal layer and stratum lacunosum moleculare of the adult hippocampus. The knock-
out mice also display an increase in the susceptibility of kainic acid-induced seizures. These 
data suggest an imbalance in excitatory/inhibitory (E/I) connectivity, which has been 
postulated to be a contributing factor to ASD etiology (Tripathi, Sgado et al. 2009).  
Post-natally, En2 is expressed in differentiating and mature granule cells. Studies by 
Emanuel DiCicco-Bloom’s group demonstrated that En2 functions to promote cell cycle exit 
and differentiation in developing granule cells (Rossman 2008). The function of En2 in 
mature adult granule cells has not been investigated but it is likely to regulate the 
expression of genes needed for synaptic plasticity and other mature neuronal functions.  
In summary although EN2 was initially selected as a candidate gene based upon similar 
cerebellar neuroanatomical phenotypes, En2 coordinates multiple developmental processes. 
In particular the protein plays an important role in regulating connectivity and 
neurotransmitter system during CNS development, both of which are relevant to ASD 
etiology.  
5. ENGRAILED 2 genetic analysis 
5.1 rs1861972-rs1861973 association in AGRE and NIMH datasets 
Human EN2 is encoded by two exons in ~8.5kb. In collaboration with Linda Brzustowicz’s 
group at Rutgers University, association analysis was initially performed in 167 Autism 
Genetic Resource Exchange families (AGRE I dataset- 745 individuals). Positive association 
with ASD was observed for the common alleles of two intronic SNPs, rs1861972 and 
rs1816973. Significant association was detected under a narrow (autism) and broad (ASD) 
diagnosis for both SNPs individually and as a haplotype (A-C rs1861972-rs1861973)(Table 
2)(Gharani, Benayed et al. 2004). These results were then replicated in two additional 
datasets (AGREII –222 families, 1102 individuals; NIMH – 129 families, 566 
individuals)(Table 2). When all three datasets were combined (518 families, 2413 
individuals) more significant results were observed (Table 2)(Benayed, Gharani et al. 2005). 
Many factors may contribute to the lack of replication in association studies of complex 
genetic traits. These include inadequate statistical power, the intrinsic complexity of a 
disease such as unknown gene-gene and gene-environment interactions as well as locus and 
allelic heterogeneity in different datasets. Given these limitations, replication of rs1861972 
and rs1861973 association supports EN2 as an ASD susceptibility gene.  
Risk for the haplotype was then determined. Individual relative risk (RR) estimates the risk 
the haplotype confers to a given individual, and is calculated by the degree to which the 
haplotype is over-transmitted from heterozygous parents to affected children. Population 
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attributable risk (PAR) estimates the risk of the haplotype to the general population and 
takes into account the degree of over-transmission and frequency of the haplotype. For the 
518 families individual RR was estimated as approximately 1.42 and 1.40 under the narrow 
and broad diagnosis respectively. Because the frequency of the rs1861972-rs1861973 A-C 
haplotype is ~67% in the combined sample, this modest individual RR corresponds to a 
significant PAR of ~39.5% and 38% for the narrow and broad diagnosis of ASD respectively 
(see Benayed et al 2005 for more details). These data imply that as much as 40% of ASD 
cases in the population are influenced by the risk allele responsible for rs1861972 and 
rs1861973 association 
 
SNP Diagnosis 
AGRE I 
(167 families, 
750 
individuals) 
AGRE II 
(222 families, 
1071 
individuals) 
NIMH 
(129 families, 
515 
individuals) 
Combined 
datasets 
(518 families, 
2336 
individuals) 
  P value P value P value P value 
rs1861972 autism .0106 .0834 .0455 .0010 
 ASD .0050 .0296 .0500 .0002 
rs1861973 autism .0073 .0268 .0234 .00008 
 ASD .0107 .0121 .0181 .000038 
A-C 
haplotype 
autism .0018 .0168 .0321 .0000205 
 ASD .0035 .0061 .0312 .0000088 
All 
haplotypes 
autism .0009 .0048 .0463 .00000065 
 ASD .0024 .0016 .0431 .00000035 
Table 2. Summary of rs1861972 and rs1861973 association data 
5.2 Additional EN2 association studies 
Prior to our association analysis for EN2, a case-control study was performed using 100 
control and affected individuals from Western/central France. Significant association was 
observed for a PvuII RFLP that we later mapped to ~2.5kb 5’ of the promoter 
(rs34808376)(Petit, Herault et al. 1995; Benayed, Gharani et al. 2005). Since our association 
analysis, 5 separate studies have reported positive results for rs1861972 or rs1861973 either 
individually or as part of a haplotype (Brune, Korvatska et al. 2007; Wang, Jia et al. 2008; 
Yang, Lung et al. 2008; Sen, Singh et al. 2010; Yang, Shu et al. 2010). These studies were 
performed in datasets recruited by the authors and represent various ethnicities 
(Northern/Western European, Chinese, Indian). However differences have also been 
observed. Additional polymorphisms have been reported to be associated and the allele for 
rs1861972 and rs1861973 that is over-transmitted to affected individuals can vary. These 
results are summarized in Table 3. These differences could reflect variations in LD blocks for 
the different ethnicities. It is also possible that different risk alleles exist in various 
populations.  
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Study Ethnicity na Associated 
polymorphisms 
ASD associated 
allele 
Petit et al Western/central French 200 PvuII CG 
Brune at al Primarily Western/ 
Northern European 
2476 rs1861972 A 
G 
Wang et al Chinese 630 rs3824068 A 
Yang et al (2008) Chinese 502 rs1861973 
rs3808331 
T 
G 
Yang et al (2010) Chinese 551 rs1861972 
rs1861973 
A 
C 
Sen et al Indian 281 rs1861973 C 
a- number of individuals recruited 
Table 3. Summary of additional EN2 association studies 
In summary EN2 association with ASD has been reported by 7 different groups. These data 
are consistent with EN2 being an ASD susceptibility gene. However if EN2 contributes to 
ASD risk, then we would expect these genetic associations to be due to the co-inheritance of 
an allele that affects either the regulation or activity of EN2. The identification of an 
associated allele that is also functional would provide additional support for EN2 being an 
ASD susceptibility gene. 
5.3 EN2 LD mapping and re-sequencing analysis 
The next step in our analysis was to identify candidate common risk alleles by performing 
linkage disequilibrium (LD) mapping. LD indicates the degree to which alleles in the human 
population segregate with each other. Two measures for LD are commonly used: D’ and r2. 
D’ takes into account recombination rate while r2 includes recombination rate and the 
frequency of the alleles in the population. For common risk alleles responsible for rs1861972-
rs1861973 association, we expected candidates to display the following criteria: 
 Candidates must display strong LD (D’ and r2 > .75) with rs1861972 and rs1861973 
 Candidates must be consistently associated with ASD 
LD mapping was then performed for 24 additional polymorphisms that were situated 
throughout the EN2 gene (Figure 3). These polymorphisms were typed in the AGRE I 
dataset and we found that only the intronic SNPs were in significant LD (D’ >0.72) with 
rs1861972 and rs1861973. We then re-sequenced the intron from individuals with ASD that 
had inherited the A-C haplotype from at least one heterozygous parent. This identified only 
1 additional polymorphism (rs28999108). Rs2899108 has a minor allele frequency of 1%, 
indicating that additional more common polymorphisms are likely not to be identified and 
ss38341503 does not fit the criteria of a common risk allele. Association analysis of all 
intronic SNPs demonstrated that none of them were as consistently or significantly 
associated as the rs1861972-rs1861973 A-C haplotype (Benayed, Gharani et al. 2005; 
Benayed, Choi et al. 2009).  
However, it was equally possible that rs1861972 and rs1861973 was in strong LD with a 
polymorphisms situated further 5’ or 3’ of EN2 that was not tested for association. If this 
were the case, we would expect these flanking SNPs to be in strong LD with rs1861972 or 
rs1861973 and therefore display r2 values similar to .767 that is observed between rs1861972 
and rs1861973. To identify other polymorphisms that fit these criteria, publicly available 
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Fig. 3. Genomic structure of EN2. The exonic/intronic structure of EN2 is illustrated. The 
position of 18 polymorphisms tested for association in Benayed et al 2005 is demarcated by 
arrows below the gene. Numbering refers to the following polymorphisms: 1-rs6150410, 2- 
PvuII (rs3480837), 3-rs1345514, 4-rs3735653, 5-rs3735652, 6-rs6460013, 7-rs7794177, 8-
rs3824068, 9-rs2361688, 10-rs3824067, 11-rs1861792, 12-rs1861973, 13- rs28999108, 14-
rs3808332, 15-rs3808331, 16-rs4717034, 17-rs2361689, 18-rs3808329, 19-rs1895091, 20-
rs12533271, 21-rs1861958, 22-rs3071184, 23-rs10259822, 24-rs10233570, 25-rs11976901, 26-
rs10243118. Red labeling denotes ASD association in published studies. 
Hapmap data was analyzed. The Hapmap project determined the LD relationship of over 1 
x 106 SNPs in four human populations (CEU– Utah residents with ancestry from northern 
and western Europe; JPT- Tokyo, Japan; CHB- Han Chinese Beijing, China; YRI-Yoruba in 
Ibadan, Nigeria). r2 and D’ values were first examined for 4 SNPs (rs1861973, rs1861973, 
rs6460013 and rs1861958) typed in both the Hapmap and ASD datasets. The values were 
found to be nearly identical, justifying this approach to identify candidate risk allele. The 
inter-marker Hapmap r2 values with rs1861973 were then determined in all four Hapmap 
datasets for SNPs within 2 Mb of EN2 (1Mb 5’ and 1 Mb 3’). Because 70.3% of the AGRE 
datasets tested for association were of Northern/Western European descent, the CEU 
Hapmap data were analyzed first and all SNPs within the 2 Mb region were found to be in 
weak r2 with rs1861973 (r2<.370). Similar results were observed for the other datasets 
(Benayed, Choi et al. 2009). These data identified the A-C haplotype as the most appropriate 
common variant to test for functional differences. 
It is also possible that rare variants on the A-C haplotype contribute to ASD risk and the 
genetic association of the haplotype with ASD. Re-sequencing over 100 individuals did not 
identify any non-synonymous coding polymorphisms (Benayed, Gharani et al. 2005, 
Rahman and Millonig, unpublished results). For all these reasons, we decided to focus our 
research on determining whether the ASD associated A-C haplotype was functional. Our 
molecular and mouse genetic studies are summarized below and demonstrate that the A-C 
haplotype functions as a transcriptional activator both in vitro and in vivo. These data 
provide molecular genetic support for EN2 being an ASD susceptibility gene.  
6. A-C haplotype functional studies 
6.1 In vitro molecular genetic analysis 
To investigate potential function of the ASD associated A-C haplotype, luciferase (luc) 
assays were conducted. The luc reporter system measures quanta of light, which is a 
sensitive and reproducible methodology for detecting transcriptional changes. Human EN2 
intron was cloned 3’ of a basal promoter and luc gene but 5’ of the polyA sequence (Figure 
4). The construct also included the EN2 splice acceptor and donor sequences. In this way the 
intron is transcribed and spliced like the endogenous gene. Constructs were generated for 
both the A-C and G-T haplotypes and are ~8kb in length. The only sequence difference 
between the constructs is the rs186972-rs1861973 haplotype.  
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Both constructs were transfected into primary cultures of cerebellar granule cells. We chose 
this cell type to test the function of the A-C haplotype for the following reasons. One, 
cerebellar granule cells are the most abundant neuronal cell type in the brain and because of 
its small size they can be isolated to near homogeneity. Two, the cells can undergo various 
steps of development in culture including proliferation, migration, and differentiation. 
Three, endogenous En2 is expressed at high levels in cerebellar granule cells.  
When we transfected our constructs, the A-C haplotype resulted in significantly higher luc 
levels compared to the promoter control after 1 day in culture. The G-T haplotype did not 
display any activity compared to the promoter (Figure 4). Electrophoretic Mobility Shift 
Assays (EMSAs) were then performed to detect DNA-protein interactions. Granule cell 
nuclear extract was employed along with a 200bp fragment encompassing either the A-C or 
G-T haplotypes. A protein complex binds significantly better to the A-C than the G-T 
haplotype (data not shown). These data demonstrate that the A-C haplotype functions as a 
transcriptional activator in vitro. The A-C haplotype is one of two ASD associated alleles for 
which function has been ascribed. 
 
 
Fig. 4. ASD-associated rs1861972-rs1861973 A-C haplotype increases gene expression. (A) 
Luciferase (luc) constructs used for transfections are diagramed: TATA – pGL3pro vector 
driven by SV40 minimal promoter, A-C and G-T – pGL3pro vector containing full-length 
human EN2 intron with ASD-associated A-C haplotype (A-C) or unassociated G-T 
haplotype (G-T). The intron was cloned 3’ of luc gene and 5’ of poly A signal so it is 
transcribed and spliced as the endogenous gene. (B) Equimolar amount of the three 
constructswere transiently transfected into P6 mouse cerebellar granule neurons and 
cultured for 24hrs. Luciferase activities were then measured and normalized to the levels of 
Renilla reniformis. Relative luc units are expressed as percent of TATA control. Note the A-C 
haplotype significantly increases luc levels. N=4, *P<.05, two tailed paired Student’s T test. 
6.2 In vivo transgenic analysis 
Because ASD is a neurodevelopmental disorder, we then generated transgenic mice to 
determine the developmental cell types and ages in which the A-C haplotype is functional. 
Our constructs include ~10kb of 5’ evolutionarily conserved sequence, the intron, and ~10kb 
of 3’ evolutionarily conserved sequence. Exon 1 of EN2 was replaced with the Ds-Red 
fluorescent reporter and exon 2 with the polyadenylation sequence. Like our luc constructs, 
the intron also includes EN2 splice acceptor and donor sequences so the intron is transcribed 
and spliced as the endogenous locus. Transgenes for both the A-C and G-T haplotypes were 
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generated with the only nucleotide difference between the ~25kb transgenes being the 
rs186172-rs1861973 haplotype (Figure 5).  
 
 
Fig. 5. Transgenic QRTPCR results. Top) Structure of the A-C and G-T transgenes is 
illustrated. Exon 1 of EN2 is replaced with the Ds-Red reporter and exon 2 with the polyA 
sequence. ~20kb of flanking evolutionarily conserved sequence (green bars) drives 
expression of Ds-Red. The only difference between the transgenes is the two nucleotides 
representing the A-C and G-T haplotypes. Bottom) QRTPCR using adult cerebellar RNA 
was performed for Ds-Red-E5 and Gapdh in two pairs of lines with similar copy numbers: 
A) A-C, line F, 5 copies; G-T, line N, 6.5 copies, B) A-C, line E, 32 copies; G-T, line I, 37 
copies. *** P<.001 T-test 
We have begun our analysis by examining the expression of the transgenes in the adult 
cerebellum because En2 is expressed specifically in granule cells. Thus we might expect to 
observe a similar difference in expression as observed for our in vitro luc analysis. Taqman 
QRTPCR was performed for Ds-Red and Gapdh on the adult cerebellar RNA isolated from A-
C and G-T lines with similar copy numbers. These assays were performed in quadruplicate 
on three A-C and 3 G-T littermates. The A-C haplotype results in ~250%% increase in 
normalized Ds-Red levels compared to the G-T haplotype in the adult cerebellum (Figure 5). 
These results demonstrate the A-C haplotype functions as a potent activator in vivo. These 
data determined that the ASD A-C haplotype functions as a transcriptional activator both in 
vitro and in vivo, providing molecular genetic evidence that EN2 contributes to ASD risk. 
We are now examining levels and spatial expression at additional time points (E12.5, E17.5, 
P6 and adult) relevant to various described functions of En2 (see Table 1). These studies will 
determine when, where, and how the A-C haplotype is functional during CNS development, 
providing the first in vivo functional analysis of any common associated allele with ASD.  
6.3 Post-mortem and epigenetic analysis 
To investigate whether EN2 levels are also increased in individuals with ASD, post-mortem 
analysis has been performed. 78 age and sex matched cerebellar samples have been obtained 
from NICHD Brain and Tissue Bank for Developmental Disorders or Harvard Brain Tissue 
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Resource Center via Autism Tissue Program (49 control, 29 affected). These samples have 
been genotyped for rs1861972 and rs1861973, and Taqman QRTPCR has been performed for 
EN2 and GAPDH. Normalized EN2 mRNA levels display a significant increase in affected 
compared to controls (Figure 6). Further examination of these data suggests that the increase 
is due to both the rs1861972-rs1861973 genotype and affection status. A more detailed 
statistical analysis is ongoing but these results are consistent with EN2 levels being 
increased in individuals with ASD. Together our in vitro, in vivo, and post-mortem studies 
have demonstrated that increased amounts of EN2 are consistently associated with ASD, 
suggesting that elevated levels of the protein alter CNS development to increase risk for 
ASD. 
 
 
Fig. 6. EN2 levels are elevated in ASD individuals. EN2 mRNA levels were measured in 29 
ASD and 49 control post-mortem cerebellum using Taqman qRT-PCR. EN2 levels were 
normalized to GAPDH internal controls and average delta Ct values were obtained from 
triplicates of qPCR. Altered EN2 levels of ASD individuals are presented as percent of 
control values. Fold difference was calculated using the formula 2-(EN2deltaCt-ControldeltaCt). Error 
bars indicate standard errors. **p<.01, T-test, two-tailed, unpaired with unequal variance. 
The previous data indicate the A-C haplotype results in increased gene expression. 
However, increased EN2 levels could also be achieved by epigenetic mechanisms. 
Environmental factors can affect gene regulation through epigenetic modifications such as 
differential methylation. Epigenetics likely plays an important role in ASD for the following 
reasons. One, epigenetics provides an interface between environmental factors and genetic 
susceptibility. Numerous common environmental factors (e.g. bis-phenol, arsenic, certain 
antibiotics) affect CpG island methylation and gene expression (Villar-Garea and Esteller 
2003). Thus differential environmental exposures could cause variations in epigenetic 
modifications and gene expression. This model provides a possible explanation for the 
phenotypic variability observed in ASD and other polygenic disorders (Bjornsson, Fallin et 
al. 2004; Feinberg 2007). In addition, the methyl-CpG binding proteins, MeCP2 and MBD2, 
are mutated in Rett Syndrome and ASD, pointing to the importance of epigenetic regulation 
in ASD (Amir, Van den Veyver et al. 1999; Li, Yamagata et al. 2005; Coutinho, Oliveira et al. 
2007; Loat, Curran et al. 2008). 
CG dinucleotides are clustered in regions called CpG islands that are regulated by 
epigenetic mechanisms. CpG dinucleotides are the substrates for cytosine methyl 
transferases and DNA methylation often leads to decreased expression. Six CpG islands 
flank human EN2 with 3 in the gene. Interestingly, a vast majority of these CpG islands are 
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not observed in mouse or rat, indicating they have evolved since rodent radiation to 
possibly regulate EN2 expression. To investigate whether EN2 is epigenetically regulated, 
we treated two human neuronal cell lines (Daoy, SH-SY5Y) that express EN2 with the 
methylation inhibitor, 5-aza-2'-deoxycytidine (AZA), and a methyl group donor, S-
adenosylmethionine (SAM). Preliminary bisulfite sequencing demonstrated methylation of 
CpGs with SAM treatment while the same dinucleotides are unmethylated in AZA treated 
cells (Figure 7). Importantly this difference in methylation is correlated with EN2 mRNA 
levels. AZA treatment results in increased expression; SAM treatment with decreased levels 
(Figure 7). Thus, these data are consistent with EN2 being epigenetically regulated 
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Fig. 7. EN2 epigenetic analysis. A and B) Treatment of Daoy and Sh-SY5Y cells with AZA 
(A) resulted in increased EN2 mRNA levels (expressed as percent difference relative to 
untreated). Treatment with SAM (B) resulted in decreased EN2 mRNA levels (expressed as 
percent difference relative to untreated). *** P<.001 T-test. Bottom) Bisulfite sequencing of 
PCR products demonstrated the EN2 promoter is hypomethylated in untreated Daoy cells 
but methylated upon SAM treatment. An unaffected post-mortem sample is methylated 
while an affected sample is methylated at the same nucleotides. 
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We have bisulfite sequenced the promoter in a few post-mortem samples. In affected 
individuals none of the CpG dinucleotides are methylated while in unaffected individuals the 
same CpGs were methylated. These CpGs are the same dinucleotides methylated after SAM 
treatment in vitro (Figure 7). In sum, these results are consistent with epigenetic differences 
contributing to the increase in EN2 mRNA levels observed in the post-mortem samples. High-
throughput epigenetic platform analysis is ongoing to investigate this hypothesis further. 
7. Future studies 
One important next step is to identify the downstream molecular and cell biological effects 
of increased EN2 expression. For this analysis we are generating a humanized EN2 knock-in 
 
 
Fig. 8. RMGR humanized EN2 knock-in. A) Genomic structure of the recombineered BACs is 
drawn to scale. Human EN2 G-T haplotype BAC was obtained and recombineered to generate 
the ASD-associated A-C haplotype. IRES:GFP was then introduced downstream of the EN2 
coding region for the A-C BAC. IRES:Cherry was introduced in the same location for the G-T 
BAC. Heterotypic loxP (orange triangle) and lox511 (blue triangle) sites were also 
recombineered into both BACs, ~35kb upstream and downstream of EN2. This genomic region 
does not include any other genes. Empty boxes depict the next flanking genes. The human 
CpG islands are also illustrated as blue boxes. B) The mouse En2 locus is illustrated with one 
small CpG island (blue box). LoxP and lox511 sites have been sequentially targeted onto the 
same En2 chromosome. C) The recombineered BACs will then be transfected into our cis loxP-
lox511 double-targeted ES cells. Cre recombinase will then be expressed in the ES cells. Since 
the heterotypic lox sites do not recombine with each other but still recognize both the cre 
recombinase, the mouse sequence will be replaced with the human locus via cre-mediated 
recombination through the flanking loxP and lox511 sites. Both A-C and G-T knock-ins will be 
generated, which will also contain the human CpG islands 
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mouse whereby we are replacing ~75kb of mouse En2 with the human sequence. This 
sequence will also contain the flanking CpG islands. To accomplish this goal we are using a 
strategy called Recombination Mediated Genome Replacement (RMGR) developed by 
Andrew Smith PhD (Figure 8)(Wallace, Marques-Kranc et al. 2007). In this way we will be 
able to determine the molecular and cell biological effects of the A-C haplotype throughout 
development. Because the human sequence will include the flanking CpG islands, we will 
also be able to expose the mice to various non-genetic factors that affect epigenetic 
regulation and investigate how these environmental compounds can either improve or 
worsen the A-C associated phenotypes. 
8. Summary  
We have demonstrated that the EN2 rs1861972-rs1861973 A-C haplotype is significantly 
associated with ASD in 3 datasets. 6 additional groups have reported EN2 ASD association, 
suggesting it is an ASD susceptibility gene. If this possibility is correct, then we would 
expect the associated alleles to segregate with common or rare variants that functionally 
alter EN2 expression or activity. To address this question, we decided to use a combinatorial 
approach that included human genetics, molecular biology, mouse transgenesis, and human 
post-mortem analysis. In the three datasets that we studied, LD mapping, re-sequencing, 
and additional association studies identified the A-C haplotype as the best candidate to test 
for function. In vitro luc assays demonstrated that the A-C haplotype functions as a 
transcriptional activator, resulting in elevated levels. Importantly transgenic mice have 
recapitulated these results in vivo and will determine when, where, and how the A-C 
haplotype is functional throughout CNS development. EN2 levels are also increased in 
individuals with ASD. Thus elevated amounts of EN2 seem to be correlated with increased 
ASD risk. Our preliminary studies indicate that EN2 is also epigenetically regulated, 
suggesting exposure to environmental non-genetic factors may also increase EN2 
expression. Future experiments are directed at identifying downstream molecular and cell 
biological pathways affected by increased EN2 levels. Finally, En2 regulates developmental 
processes implicated in ASD, including the establishment of connectivity maps. In sum, our 
combinatorial approach has provided evidence that EN2 is an ASD susceptibility gene.  
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